Orca Bio is a late-stage biotechnology company developing high-precision allogeneic cell therapies for the treatment of blood cancers and autoimmune diseases. The company uses a single-cell precision manufacturing platform to create personalized cell therapy products intended to replace a patient’s diseased blood and immune system with a healthy one.
Estimated Valuation
Powered by
Leadership & Board
- Current Number of Employees
- 389
- Current LinkedIn Followers
- 25,933
Latest Estimated Valuation
- Total Amount Raised
- $250M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $250M
- Latest Funding Round
- Series F
Company Momentum Positive
Orca Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Orca Bio had 389 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Orca Bio had 25,933 followers as of October 26, 2026. The number of followers increased by 61 (0.24%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 09, 2026 | Series F | $250.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Lightspeed Venture Partners | Series F |
Similar Companies
A snapshot of private companies similar to Orca Bio, helping you discover and navigate related company profiles.
Related News and Analysis
